Healthcare Finance News October 31, 2023
Jeff Lagasse

Final rule increases payment for certain new renal dialysis drugs and biological products.

In a final rule, the Centers for Medicare and Medicaid Services is increasing the end-stage renal disease (ESRD) prospective payment system (PPS) base rate to $271.02, increasing total payments to ESRD facilities by about 2.1% in an update to payment rates and policies regarding renal dialysis services furnished to Medicare beneficiaries on or after January 1.

The rule also updates the acute kidney injury (AKI) dialysis payment rate for renal dialysis services furnished by ESRD facilities for 2024, and updates requirements for the ESRD Quality Incentive Program (QIP).

The CY 2024 ESRD PPS final rule also includes several changes related to ESRD PPS payment policies. First, this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Post-Acute Care, Provider
CMS proposes new guardrails on Medicare Advantage prior authorizations, marketing
CMS finalizes new kidney transplant model: 10 things to know
CMS' proposed changes to Medicare Advantage: 10 things to know
Medicare Advantage Plans' Prior Auth Rules Would Be Made Public Under CMS Proposal
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule

Share This Article